News
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
Stacker on MSN15h
How to find out if weight loss drugs are covered by your insurance, and what to do if they're notGoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
The Print on MSN9h
India sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arenaIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...
The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback